Search results
Pfizer (PFE) Q4 2023 Earnings Call Transcript
Motley Fool via Yahoo Finance· 4 months agoImage source: The Motley Fool. Pfizer (NYSE: PFE) Q4 2023 Earnings Call Jan 30, 2024, 10:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call...
Pfizer buys Seagen for $43B, boosts access to cancer drugs
Associated Press via Yahoo News· 1 year agoPfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor...
Pfizer Plant Damaged After North Carolina Tornado, 'Long-Term Shortages' of Medicine are Likely,...
People via Yahoo News· 11 months agoA warehouse at Pfizer’s Rocky Mount, North Carolina facility — which holds “finished medicines” —...
Pfizer 'surprised' by Moderna COVID-19 vaccine patent lawsuit
Yahoo Finance· 2 years agoModerna (MRNA) said Friday it is suing Pfizer and BioNTech (PFE/BNTX), alleging the rival drug...
Why Pfizer Stock Blasted More Than 6% Higher Today
Motley Fool via Yahoo Finance· 1 month agoPfizer (NYSE: PFE) stock got a very effective shot in the arm on Wednesday. This was supplied by its latest earnings release, which saw the storied...
Could Pfizer Stock Help You Become a Millionaire?
Motley Fool via Yahoo Finance· 6 months agoHaving at least $1 million in the bank by retirement has long been a popular goal, but it isn't easy to accomplish. One of the best ways to do so is to...
Where Will Pfizer Be in 5 Years?
Motley Fool· 8 months agoPfizer (NYSE: PFE) is a company that's in the midst of a transition. The COVID-19 vaccine maker benefited from a huge revenue boost due to the pandemic....
Pfizer restarts drug production following Rocky Mount tornado. But supply risk remains.
Raleigh News and Observer via AOL· 8 months agoMore than two months after a 150 mph tornado ripped through the Pfizer plant in Rocky Mount, raising...
Is the Worst Over for Pfizer?
Motley Fool via Yahoo Finance· 4 months agoPfizer (NYSE: PFE) celebrates its 175th anniversary this year, so the pharma giant has a long history. But the drugmaker actually jumped into the global...
Why I'm Considering Selling Pfizer for Tax-Loss Harvesting Purposes
Motley Fool· 6 months agoOne stock I'm considering letting go is pharma giant Pfizer (NYSE: PFE). Here are two other issues...
